All articles tagged: Secondary malignant neoplasm of breast (C79.81)

Factors aside from neighborhood deprivation are responsible for increased breast cancer mortality among Black women, according to a study published online June 12 in JAMA Network Open.Lauren E. Barber, Ph.D., from the Emory University Rollins School of Public Health in Atlanta, and colleagues investigated whether neighborhood depri

The USPSTF recommends biennial mammograms for women aged 40-74 to reduce late-stage diagnoses. Critics argue for annual screenings, citing disparities and benefits.

The WHO projects global cancer cases to reach 35 million by 2050, driven by lifestyle and environmental factors. The report underscores significant regional disparities in cancer care and an increasing trend of younger people being affected.

Recent research has shown that breast cancer cells, when nutrient-deprived, consume their surrounding extracellular matrix. This survival strategy, involving macropinocytosis and amino acid metabolism, opens new avenues for breast cancer therapies​​.

Women with non-screen-detected ductal carcinoma in situ have an increased risk for invasive breast cancer and breast cancer death, according to a study published online Jan. 24 in The BMJ.Gurdeep S. Mannu, M.B.B.S., D.Phil., from the University of Oxford in the United Kingdom, and colleagues examined the long-term risks for invasive c

In the United States, breast cancer screening and treatment were associated with a 58 percent reduction in breast cancer mortality in 2019 compared with 1975, according to a study published in the Jan. 16 issue of the Journal of the American Medical Association.Jennifer L. Caswell-Jin, M.D., from the Stanford University School of Medic

For patients undergoing surveillance following diagnosis and treatment of ductal carcinoma in situ (DCIS), very few second breast cancers are detected by clinical breast examination by a physician, according to a study published online Dec. 28 in the Journal of the National Comprehensive Cancer Network.Bethany T. Waites, M.D., from the

Across European populations, an artificial intelligence (AI) risk model shows generalizable discriminatory performance for predicting breast cancer among women with a negative mammogram, according to a study published online Dec. 6 in The Lancet Regional Health: Europe.Mikael Eriksson, Ph.D., from the Karolinska Institutet in Stockholm

Most women report that their clinicians counsel them about breast density, according to a study published online Nov. 27 in JAMA Network Open.Nancy R. Kressin, Ph.D., from Boston University School of Medicine, and colleagues conducted a telephone survey of 770 women to examine the content of women's reports of breast density disc

The annual San Antonio Breast Cancer Symposium was held from Dec. 5 to 9 in San Antonio, with attendees including medical oncologists, radiation oncologists, researchers, and other health care professionals. The conference highlighted recent advances in the risk, diagnosis, treatment, and prevention of breast cancer, and presentations focused on emerging tr

Serum hormone concentrations can help ascertain which women with breast cancer will benefit from anastrozole treatment, according to a study published online Dec. 6 in The Lancet Oncology to coincide with the annual San Antonio Breast Cancer Symposium, held from Dec. 5 to 9 in San Antonio.Jack Cuzick, Ph.D., from Queen Mary University o

For women with breast cancer aged 50 years or older and three years postdiagnosis, outcomes are no worse with less frequent mammograms than annual mammograms, according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 5 to 9 in San Antonio.Janet A. Dunn, Ph.D., from the University of Warwick in the United Kin

Twenty-two percent of young BRCA carriers conceive within 10 years after diagnosis of breast cancer, according to a study published online Dec. 7 in the Journal of the American Medical Association to coincide with the annual San Antonio Breast Cancer Symposium, held from Dec. 5 to 9 in San Antonio.Matteo Lambertini, M.D., from t

For postmenopausal women aged 50 to 69 years with stage 1 hormone receptor-positive breast cancer, the risk for recurrence is very low for those who do not undergo radiotherapy after breast-conserving surgery (BCS), according to a study published online Dec. 7 in the Journal of Clinical Oncology to coincide with the annual San Antonio Breast

Patients who present with breast cancer with axillary node involvement (cN+) who are found to be pathologically node-negative at surgery (ypN0) after neoadjuvant chemotherapy can avoid regional nodal irradiation (RNI), according to a study presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 5 to 9 in San Antonio.Elefther

Minorities often feel a deep sense of dread before doctor appointments, and some even try to dress especially well for their visit to try and ward off the possibility they will face insults or unfair care. According to a new poll conducted by hea

The inclusion of additional risk factors improves the predictive value of the Breast Cancer Surveillance Consortium (BCSC) version 2 model for identifying women at risk for invasive breast cancer, according to a study published online Nov. 17 in the Journal of Clinical Oncology.Charlotte C. Gard, Ph.D., from New Mexico State Univ

In a clinical practice guideline issued by the American Society for Radiation Oncology (ASTRO) published online Nov. 15 in Practical Radiation Oncology, recommendations are presented to inform best clinical practices on the use of partial breast irradiation (PBI).Simona F. Shaitelman, M.D., from the University of Texas MD Anderson Cancer

For patients with hormone receptor (HR)-positive HER2-mutant metastatic breast cancer (MBC) with progression on cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) therapy, neratinib + fulvestrant + trastuzumab (N + F + T) is beneficial, according to a study published in the October issue of the Annals of Oncology.Komal Jhaveri, M

For patients with early-stage breast cancer treated with neoadjuvant chemotherapy (NACT), Blacks have higher mortality risk than Whites, according to a study published online Nov. 22 in JAMA Network Open.Arya Mariam Roy, M.D., from the Roswell Park Comprehensive Cancer Center in Buffalo, New York, and colleagues examined racial and ethn

For patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, pyrotinib plus capecitabine offers an overall survival benefit, according to a study presented at the Advanced Breast Cancer Seventh International Consensus Conference, held from Nov. 9 to 11 in Lisbon, Portugal.Binghe Xu, M.D., from the Chines

In the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according to a study published online Nov. 9 in JAMA Oncology.Leticia M. Nogueira, Ph.D., M.P.H., from the American Cancer Society in Kennesaw, Georgia, and coll

Receipt of government housing assistance is associated with increased rates of breast cancer (BC) and colorectal cancer (CRC) screening, according to a study published online Nov. 8 in the American Journal of Preventive Medicine.Jordan Baeker Bispo, Ph.D., from the American Cancer Society in Atlanta, and colleagues used data from

Pretreatment vitamin D insufficiency is associated with an increased incidence of grade ≥3 chemotherapy-induced peripheral neuropathy (CIPN) from paclitaxel, according to a study published in the November issue of the Journal of the National Comprehensive Cancer Network.Ciao-Sin Chen, Pharm.D., Ph.D., from the University of Michigan C

The annual meeting of the American College of Surgeons was held this year from Oct. 22 to 25 in Boston and attracted participants from around the world, including surgeons, medical experts, allied health professionals, and administrators. The conference included hundreds of general and

Fewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State University Comprehensive Cancer Center: The James (OSUCCC-James). The survey was conducted online (974 participants) and via telephone (30 participants) from Sep

The risk for developing breast cancer after a false-positive mammography result varies with age, breast density, and follow-up, according to a study published online Nov. 2 in JAMA Oncology.Xinhe Mao, from the Karolinska Institutet in Stockholm, and colleagues conducted a matched cohort study in Sweden from Jan. 1, 1991, to March 31, 202